Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid for Diabetic Macular Edema (DME) Study
NCT07843849Phase 4Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, fluocinolone in diabetic macular edema (DME), sponsored by Vanderbilt University Medical Center. Started Apr 2026; status: recruiting.
02
Drugs
dexamethasonefluocinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07843849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843849.